FDA.reportPublic FDA data

everolimus 10 MG Oral Tablet

RxCUI
845507
RxNorm name
everolimus 10 MG Oral Tablet
Display name
everolimus 10 MG Oral Tablet
Full name
everolimus 10 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EverolimusEVEROLIMUSHikma Pharmaceuticals USA Inc.5aaf2fb7-93f6-40d6-941a-9583a3794ce72026-08-14Warnings, Adverse reactionsExact identifier
rxcui: 845507
EverolimusEVEROLIMUSTeva Pharmaceuticals USA, Inc.e3bca36b-29ed-4a2b-a1be-a57b6af805f62026-06-29Warnings, Adverse reactionsExact identifier
rxcui: 845507
TORPENZEVEROLIMUSUpsher-Smith Laboratories, LLC4c0075dd-a0a8-4dc4-be32-1be8383fbbdc2026-06-10Warnings, Adverse reactionsExact identifier
rxcui: 845507
AfinitorEVEROLIMUSNovartis Pharmaceuticals Corporation2150f73a-179b-4afc-b8ce-67c85cc72f042026-06-01Warnings, Adverse reactionsExact identifier
rxcui: 845507
YulithiraEVEROLIMUSCivicaScript, LLC5e325efa-8ae6-4dac-b59b-d7c74c73186c2026-03-31Warnings, Adverse reactionsExact identifier
rxcui: 845507
everolimusEVEROLIMUSNovugen Pharma (USA) LLC.67e62e26-448d-46ec-b5a1-00dc1b5e26c62026-03-10Warnings, Adverse reactionsExact identifier
rxcui: 845507
EverolimusEVEROLIMUSBreckenridge Pharmaceutical, Inc.01f7b5fb-be0d-4adf-acd2-6899018de9662025-09-05Warnings, Adverse reactionsExact identifier
rxcui: 845507
EVEROLIMUSEVEROLIMUSBiocon Pharma Inc.5fb55800-f322-6bb6-9dde-622925ef28bd2025-03-21Warnings, Adverse reactionsExact identifier
rxcui: 845507
EVEROLIMUSEVEROLIMUSNorthStar RxLLC5cfca904-b75c-5a39-8cb9-b99bb421bceb2024-08-02Warnings, Adverse reactionsExact identifier
rxcui: 845507
EverolimusEVEROLIMUSNatco Pharma Limitede3dbbc24-7e55-4069-a305-e2cded2db6412023-06-08Warnings, Adverse reactionsExact identifier
rxcui: 845507

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2150f73a-179b-4afc-b8ce-67c85cc72f04everolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]266These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 200920260212
45d54974-3fc4-4237-a2fa-3158ca1a8105everolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]223These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920260116
01f7b5fb-be0d-4adf-acd2-6899018de966everolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]220These highlights do not include all the information needed to use EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets, for oral use EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 200920250905
4c0075dd-a0a8-4dc4-be32-1be8383fbbdceverolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use TORPENZ TABLETS safely and effectively. See full prescribing information for TORPENZ TABLETS. TORPENZ™ (everolimus) tablets, for oral use Initial U.S. Approval: 200920260215
5fb55800-f322-6bb6-9dde-622925ef28bdeverolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920250321
e3bca36b-29ed-4a2b-a1be-a57b6af805f6everolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]210These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS . EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920260309
5aaf2fb7-93f6-40d6-941a-9583a3794ce7everolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]29These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920240423
e3dbbc24-7e55-4069-a305-e2cded2db641everolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]27These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920230608
5cfca904-b75c-5a39-8cb9-b99bb421bcebeverolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use EVEROLIMUS safely and effectively. See full prescribing information for EVEROLIMUS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920240802
67e62e26-448d-46ec-b5a1-00dc1b5e26c6everolimus 10 MG Oral Tablet [PSN] · everolimus 10 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 200920260310